Development of Myasthenia Gravis due to Treatment of Chronic Hepatitis C with a Combination of Interferon-Alpha and Ribavirin

By  

Digestion, Vol. 75, Iss. 4, 2007-10 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment

By Mamori Satoshi   Suzuki Fumitaka   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 776-782

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment with Interferon-Alpha and Ribavirin in Primary Interferon-Alpha Non-Responders with Chronic Hepatitis C

By  

Digestion, Vol. 61, Iss. 2, 2000-02 ,pp. : 90-97

Karger

Access to resources Recommend Favorite

How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients

By Kasahara Akinori  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1125-1126

Springer Publishing Company

Access to resources Recommend Favorite

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

By Gramenzi Annagiulia   Andreone Pietro   Cursaro Carmela   Verucchi Gabriella   Boccia Sergio   Giacomoni Pier Luigi   Galli Silvia   Furlini Giuliano   Biselli Maurizio   Lorenzini Stefania   Attard Luciano   Bonvicini Fiorenza   Bernardi Mauro  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 362-367

Springer Publishing Company

Access to resources Recommend Favorite